Fulgent Genetics: From Genetic Code To Cancer Cure - Why I Assign A Hold Rating
Source: SeekingAlpha
2025-12-02 08:05:36 ET
...
Read the full article on Seeking Alpha
For further details see:
Fulgent Genetics: From Genetic Code To Cancer Cure - Why I Assign A Hold Rating
Fulgent Genetics Inc.
NASDAQ: FLGT
FLGT Trading
-1.44% G/L:
$14.34 Last:
283,822 Volume:
$14.17 Open:
FLGT Latest News
February 12, 2026 07:30:00 am
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026
FLGT Stock Data
$726,441,212
20,677,299
5.21%
56
N/A
Medical Diagnostics & Screening
Healthcare
US
El Monte
